IRWD
Ironwood Pharmaceuticals Inc
3.80$
+3.3%
vs. previous close
Closing price · As of: Oct 7, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -1,067.9% | -64.6% | -126.9% | -11.1% | -154.8% | -114.2% | -46.3% | -1,194.7% | -203.5% | -71.5% | -9.3% | -33.4% | -20.4% | 2.5% | 43.3% | 63.3% | 66.7% | 41.4% | 29.5% | 42.9% | |
| 40.1% | 16.5% | 12.8% | 14.5% | 14.0% | 15.2% | 7.5% | 51.3% | 16.1% | 7.8% | 4.1% | 4.9% | 4.1% | 1.3% | 0.9% | 0.4% | 0.3% | 0.4% | 0.6% | 0.6% | |
| – | 11.0% | 12.6% | 14.5% | 17.1% | 17.8% | 11.7% | 86.7% | 34.3% | 17.0% | 10.7% | 11.3% | 12.7% | 7.3% | 8.0% | 5.4% | 6.6% | 7.2% | 8.5% | 5.8% | |
| – | – | – | – | – | 17.8% | 11.7% | 89.3% | 61.0% | 28.7% | 28.2% | -5.3% | 30.1% | 21.0% | 5.0% | -77.7% | 22.3% | – | – | – | |
| 68.2% | 432.3% | 93.0% | 161.2% | -48.5% | -52.2% | -18.0% | -156.0% | -39.4% | -25.6% | -1.8% | -7.3% | 2.2% | -23.3% | -0.2% | 4.3% | 0.7% | 2.5% | 0.2% | 13.4% | |
| 89.9% | 25.3% | 103.2% | 11.2% | 39.3% | 14.7% | 9.3% | 41.9% | 4.6% | 2.7% | 38.0% | 1.4% | 2.5% | 1.7% | 0.5% | 0.1% | 0.0% | 0.1% | 0.0% | 0.0% | |
| -178.8% | -263.8% | -67.8% | 49.2% | -485.8% | 174.7% | 20.0% | -443.3% | -74.0% | -6.1% | -64.9% | 50.8% | 25.6% | -2.6% | -0.5% | -0.1% | 0.0% | -231.8% | 0.0% | 0.0% | |
| – | – | – | – | – | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | – | – | – | – | 27.1% | – | – | – | |
| – | – | – | – | – | 0.0% | 56.7% | 602.1% | 249.1% | 47.4% | 9.1% | 8.8% | 9.2% | 3.2% | 4.8% | -5.8% | -30.8% | 0.0% | 0.0% | – | |
| – | – | – | – | – | -0.4% | -0.2% | 727.7% | -2.9% | -9.4% | -10.6% | 2.9% | -0.5% | 3.8% | -31.0% | -29.2% | -29.4% | 67.8% | -32.7% | 0.0% | |
| 2,550.6% | 484.7% | 218.6% | 115.4% | 462.8% | 4.8% | 59.2% | 1,370.5% | 276.0% | 202.6% | -1.5% | 6.6% | 8.7% | -0.3% | 4.8% | -1.1% | -57.9% | 62.6% | -30.4% | 0.1% | |
| – | 156.3% | 23.8% | 153.5% | -177.8% | 65.2% | 32.9% | -267.5% | -1.6% | 125.0% | -75.7% | 24.0% | 13.9% | -0.4% | 47.6% | 62.1% | 8.8% | -127.8% | -1.0% | 42.8% | |
| -1,157.8% | -89.9% | -230.1% | -22.3% | -194.1% | -128.9% | -55.7% | -1,236.6% | -208.2% | -74.2% | -47.3% | -34.8% | -22.9% | 0.8% | 42.9% | 63.2% | 66.6% | 41.4% | 29.4% | 42.9% |
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.